Sedláček Dalibor, Hofman Sam, Frei Jiří, Malý Marek
Department of Infectious Diseases and Travel Medicine, Faculty of Medicine in Pilsen, Charles University, and University Hospital Pilsen, Pilsen, Czech Republic.
Faculty of Health Studies, University of Western Bohemia, Pilsen, Czech Republic.
Cent Eur J Public Health. 2025 Mar;33(1):12-16. doi: 10.21101/cejph.a7382.
The aim of the study was the assessment of adherence to antiretroviral (ARV) treatment in a population of people living with HIV (PWH), improving the awareness of PWH, drawing attention to the risk of developing HIV drug resistance and subsequent treatment failure.
The basic cohort consisted of PWH followed up long-term at the HIV centre of the University Hospital Pilsen. Adherence to treatment was assessed by ARV levels. Nucleoside analogs were determined in urine by high pressure liquid chromatography (HPLC), in relation to clinical data, viral load (HIV RNA), and absolute CD4 and CD8 T cell counts. To assess mental and physical state of the patients, a modified SF-36 questionnaire was used to measure social relationships, education and ability to relax.
From a group of 131 PWH, 18 (13.7%) with zero levels and 113 (86.3%) with any detectable ARV levels were followed for 6-12 months. A statistically significant lower viral load was demonstrated in patients who adhered to the treatment at the time of the test as indicated by ARV levels in the urine. CD4 T lymphocyte values in adherent patients were, as expected, statistically significantly higher. A significant difference for CD8 T lymphocyte was not demonstrated. A survey assessed subjective factors influencing the degree of adherence. PWH consider important: quality care enabling trust, low risk of developing opportunistic infections, self-sufficiency, quality of sleep, managing leisure activities, and good family relationships. Quality of life evaluation and satisfaction in the monitored areas were similar in both groups of PWH.
Non-adherence leads to deterioration of CD4 and viral load levels and may be the cause of the development of HIV drug resistance and treatment failure on the part of the patient. PWH with zero or low urinary nucleoside levels were repeatedly instructed about the need for regular and sustained medication use. Regular checks with a laboratory examination service are needed to detect early emergence of resistance and side effects of the treatment, which are initially only detectable in the laboratory.
本研究旨在评估艾滋病毒感染者(PWH)对抗逆转录病毒(ARV)治疗的依从性,提高PWH的认识,引起对产生艾滋病毒耐药性及后续治疗失败风险的关注。
基本队列由长期在皮尔森大学医院艾滋病毒中心接受随访的PWH组成。通过ARV水平评估治疗依从性。采用高压液相色谱法(HPLC)测定尿液中的核苷类似物,并与临床数据、病毒载量(HIV RNA)以及绝对CD4和CD8 T细胞计数相关联。为评估患者的心理和身体状况,使用改良的SF - 36问卷来衡量社会关系、教育程度和放松能力。
在131名PWH中,18名(13.7%)的ARV水平为零,113名(86.3%)有任何可检测到的ARV水平,对其进行了6至12个月的随访。如尿液中的ARV水平所示,在检测时坚持治疗的患者中,病毒载量在统计学上显著较低。正如预期的那样,坚持治疗的患者的CD4 T淋巴细胞值在统计学上显著更高。CD8 T淋巴细胞未显示出显著差异。一项调查评估了影响依从程度的主观因素。PWH认为重要的因素包括:能够建立信任的优质护理、发生机会性感染的低风险、自给自足、睡眠质量、管理休闲活动以及良好的家庭关系。两组PWH在监测领域的生活质量评估和满意度相似。
不依从会导致CD4和病毒载量水平恶化,可能是患者产生艾滋病毒耐药性和治疗失败的原因。对于尿液核苷水平为零或低的PWH,反复告知其定期持续用药的必要性。需要通过实验室检查服务进行定期检查,以检测耐药性的早期出现和治疗的副作用,这些最初只能在实验室中检测到。